TickerFactsScreenerDevelopers

Oncotelic Therapeutics, Inc. (OTLC) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2008: $28.74M2009: $5.80M2010: -$5.25M2011: $8.80M2012: $4.55M2013: $6.04M2014: $29.00M2015: $25.35M2016: $12.50M2017: -$483.6K2018: $2.46M2019: $16.90M2020: $11.77M2021: $7.96M2022: $19.41M2023: $12.13M2024: $8.25M2025: $262.76M$262.76M
2008Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$262.76M+3084.3%
2024$8.25M-32.0%
2023$12.13M-37.5%
2022$19.41M+144.0%
2021$7.96M-32.4%
2020$11.77M-30.4%
2019$16.90M+585.7%
2018$2.46M+609.7%
2017-$483.6K-103.9%
2016$12.50M-50.7%
2015$25.35M-12.6%
2014$29.00M+380.0%
2013$6.04M+32.9%
2012$4.55M-48.3%
2011$8.80M+267.4%
2010-$5.25M-190.6%
2009$5.80M-79.8%
2008$28.74M—